Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro.
Walker, A B
Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. [electronic resource] - Diabetes May 1998 - 810-4 p. digital
Publication Type: Clinical Trial; Journal Article
0012-1797
10.2337/diabetes.47.5.810 doi
Adipose Tissue--blood supply
Animals
Arteries--drug effects
Chromans--pharmacology
Diabetes Mellitus, Type 2--drug therapy
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Humans
Hypoglycemic Agents--pharmacology
Male
Rats
Rats, Wistar
Rosiglitazone
Thiazoles--pharmacology
Thiazolidinediones
Troglitazone
Vasodilator Agents--pharmacology
Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. [electronic resource] - Diabetes May 1998 - 810-4 p. digital
Publication Type: Clinical Trial; Journal Article
0012-1797
10.2337/diabetes.47.5.810 doi
Adipose Tissue--blood supply
Animals
Arteries--drug effects
Chromans--pharmacology
Diabetes Mellitus, Type 2--drug therapy
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Humans
Hypoglycemic Agents--pharmacology
Male
Rats
Rats, Wistar
Rosiglitazone
Thiazoles--pharmacology
Thiazolidinediones
Troglitazone
Vasodilator Agents--pharmacology